Kristine Anne Gordon

Kristine Anne Gordon has over 25 years of work experience in the biopharmaceutical industry. Kristine Anne is currently serving as the Senior Director and Head of Program Management at Nine Square Therapeutics since July 2022. Prior to this, they worked at Frontier Medicines as the Senior Director of Program and Alliance Management from November 2020 to June 2022.

From June 2016 to November 2020, Kristine worked at Pfizer as the Director of Project Management in the Centers for Therapeutic Innovation (CTI). Kristine Anne was responsible for leading various projects in therapeutic innovation.

In their earlier career, Kristine served as a Scientist in Preclinical Research at Seattle Genetics for 15 years, from 2001 to 2016. Kristine Anne made significant contributions to the development of preclinical research projects.

Before that, they worked as a Research Associate in Immunology at Xcyte Therapies from May 2000 to December 2000. Kristine Anne was involved in immunology-based research projects.

Kristine began their career as a Research Scientist at the University of Washington in the Mary-Claire King Lab from 1996 to 2000. Kristine Anne conducted research in various scientific areas.

Throughout their career, Kristine has gained extensive experience in program management, project management, and research in the biopharmaceutical industry.

Kristine Anne Gordon has a Bachelor of Science (BS) degree in Biology (Cell and Molecular) with a minor in Anthropology from the University of Washington. In addition to their degree, they have obtained several certifications. In 2015, they earned a Certificate in Project Management from Bellevue College. In 2016, they completed the Clinical Project Management Fundamentals course from Barnett International and the Drug Safety & Adverse Events Reporting course from Corexcel. Most recently, in February 2019, they obtained the Project Management Professional (PMP) certification from the Project Management Institute.